| Name | 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2,4-diamine |
|---|
| Molecular Formula | C10H17BN4O2 |
|---|---|
| Molecular Weight | 236.07900 |
| Exact Mass | 236.14400 |
| PSA | 97.74000 |
|
~26%
944401-61-0 |
| Literature: NOVARTIS VACCINES AND DIAGNOSTICS, INC. Patent: WO2008/98058 A1, 2008 ; Location in patent: Page/Page column 64-65 ; WO 2008/098058 A1 |